Alcista
$1.53
Precio del escenario
$1.370
+0.131 (+9.59%)Al cierre
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
Agape ATP Corp (ATPC) is not a good buy right now due to its significant price decline and poor financial performance. The current price is $1.25, which is 97.97% lower than its 1-year high of $73.50. The RSI is at 33.51, indicating that the stock is oversold but lacks momentum for recovery. Furthermore, the forward P/E ratio is 0, suggesting no earnings growth expectations, and the gross margin is only 85.96%, which, while high, is overshadowed by the company's overall financial instability. The main risk is the 76.19% year-to-date decline, indicating severe market sentiment against the stock.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Agape ATP Stock Surges After Regaining Nasdaq Compliance

Agape ATP Regains Nasdaq Compliance with Minimum Bid Price

AGAPE ATP Shares Soar 130% After Energy Trading Deal

AGAPE ATP CORP ANNOUNCES STRATEGIC PARTNERSHIP WITH CITADEL INVESTMENT LLC - SEC FILING

Agape ATP Faces Potential Nasdaq Delisting Risk
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual. It operates in the Healthcare sector.
Agape ATP Corp (ATPC) is not a good buy right now due to its significant price decline and poor financial performance. The current price is $1.25, which is 97.97% lower than its 1-year high of $73.50. The RSI is at 33.51, indicating that the stock is oversold but lacks momentum for recovery. Furthermore, the forward P/E ratio is 0, suggesting no earnings growth expectations, and the gross margin is only 85.96%, which, while high, is overshadowed by the company's overall financial instability. The main risk is the 76.19% year-to-date decline, indicating severe market sentiment against the stock.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.